DMAA
Drugs Made In America Acquisition Corp.
10.65
5 x 10.62
5 x 10.54
bid
ask
+
0.01
0.09%
11:11 AM
timesize
| Ytd | 2.70% | |
| 1y | 4.51% |
10.65
day range
10.65
10.17
52 week range
10.65
| Open | 10.65 | Prev Close | 10.64 | Low | 10.65 | High | 10.65 | Mkt Cap | 258.55M |
| Vol | 107.00 | Avg Vol | 116.62K | EPS | 0.20 | P/E | 53.25 | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-20 | 50-d Avg | 10.60 | 200-d Avg | 10.44 | 1yr Est | 0.00 |
DMAA News
benzinga.com
Drugs Made in America Acquisition Corp. Signs LOI For $1B De-SPAC Deal With Power Analytics Global
On April 7, 2026, Drugs Made in America Acquisition Corp. (the "Company") entered into a let
defenseworld.net
Drugs Made In America Acquisition Corp. $DMAA Shares Sold by DLD Asset Management LP
DLD Asset Management LP reduced its stake in Drugs Made In America Acquisition Corp. (NASDAQ: DMAA)